13 May 2015 : Review article
Metalloproteinases – their Role in Inflammatory Processes and Central Nervous System Diseases
Kinga BobińskaABCDEFGDOI: 10.12659/MSRev.894260
Med Sci Rev 2015; 2:35-40
Abstract
MMPs belong to zinc endopeptidases. MMPs degrade a wide spectrum of extracellular matrix proteins and are constitutively expressed in a large number of cell and tissue types. The physiological role of MMP includes angiogenesis, embryogenesis and tissue remodelling by proliferation, migration, differentiation and adhesion. In pathological processes MMP has been indicated in Alzheimer disease, cancers, and cardiovascular diseases. MMPs degrade numerous receptors on the surface of cells as well as activate and deactivate growth factors, cytokines and chemokines. These processes prove why MMP has been shown to modulate inflammation. Metalloproteinases (MMPs) have a direct and indirect effect on the Blood Brain Barrier (BBB) owing to their role in inflammatory processes. It has also been proved that cardiovascular diseases, brain and heart strokes, multiple sclerosis and cancers are dysfunctions connected with a higher risk of depression onset. It is said that an inflammatory process may be a potential link between the aforementioned diseases and depression. Protein levels of MMPs are corresponding to gene expression and are associated with clinical outcome. Gelatin zymography is one of the most commonly utilised methods for the quantification of MMPs. MMPs are engaged in the pathophysiology of inflammatory processes. In recurrent depressive disorders, inflammation plays the key role not only on the brain tissue level. It has been suggested that inflammation may be associated with depression and cardiovascular dysfunctions. An association between MMP genotype and clinical outcome seems to play the key role in genotyping in clinical practice. Further, MMP detecting and reacting may be considered a possible target for the development of new therapies against disorders of the nervous and vascular systems.
Keywords: Central Nervous System, Depression, Matrix Metalloproteinases
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952